About AuriGen Medical
AuriGen Medical is a company based in Galway (Ireland) founded in 2016 by John Thompson and Tony O Halloran. AuriGen Medical has raised $2.9 million across 6 funding rounds from investors including EIT Health and European Union. AuriGen Medical offers products and services including Zenith LAAO Device. AuriGen Medical operates in a competitive market with competitors including AtaCor Medical, AtriCure, CardioFocus, Kestra Medical Technologies and EBR Systems, among others.
- Headquarter Galway, Ireland
- Founders John Thompson, Tony O Halloran
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aurigen Medical Uk Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.9 M (USD)
in 6 rounds
-
Latest Funding Round
$2.69 M (USD), Grant
Jun 01, 2023
-
Investors
EIT Health
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AuriGen Medical
AuriGen Medical offers a comprehensive portfolio of products and services, including Zenith LAAO Device.
Implantable device for occluding the left atrial appendage to prevent strokes.
People of AuriGen Medical
Unlock access to complete
Unlock access to complete
Funding Insights of AuriGen Medical
AuriGen Medical has successfully raised a total of $2.9M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $2.69 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AuriGen Medical
AuriGen Medical has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include EIT Health and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for AuriGen Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AuriGen Medical
Investment portfolio details for AuriGen Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AuriGen Medical
Detailed financials for AuriGen Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aurigen Medical Comparisons
Peer comparison for AuriGen Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AuriGen Medical
AuriGen Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtaCor Medical, AtriCure, CardioFocus, Kestra Medical Technologies and EBR Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| Locked | Locked | Locked |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| Locked | Locked | Locked |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| Locked | Locked | Locked |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| Locked | Locked | Locked |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
Detailed competitors of AuriGen Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aurigen Medical
Complete news archive for AuriGen Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AuriGen Medical
AuriGen Medical was founded in 2016 and raised its 1st funding round 2 years after it was founded.
AuriGen Medical is headquartered in Galway, Ireland.
John Thompson is the current CEO of AuriGen Medical. They have also founded this company.
AuriGen Medical is a funded company, having raised a total of $2.9M across 6 funding rounds to date.
AuriGen Medical was established in 2016 in Galway, Ireland, within the medical devices sector. Trans-septal implants are developed to manage atrial fibrillation, addressing related conditions including stroke and arrhythmia. Operations are based in Ireland, with a focus on innovative implantation technologies for cardiac care. Leadership includes co-founders serving as CEO and CTO.
AuriGen Medical's top competitors include AtaCor Medical, AtriCure and CardioFocus.
AuriGen Medical offers Zenith LAAO Device.
AuriGen Medical has 2 investors. Key investors include EIT Health, and European Union.